Rifabutin-based 10-day and 14-day triple therapy as a third-line and fourth-line regimen for Helicobacter pylori eradication: A pilot study

BACKGROUND AND AIM: This prospective randomized study was designed to assess the efficacy of 10-day and 14-day rifabutin-based triple therapy as a third- or fourth-line rescue therapy. METHODS: Patients who failed first- and second-line eradication therapy were enrolled. H. pylori was isolated from...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:United European Gastroenterol J
Main Authors: Mori, Hideki, Suzuki, Hidekazu, Matsuzaki, Juntaro, Tsugawa, Hitoshi, Fukuhara, Seiichiro, Miyoshi, Sawako, Hirata, Kenro, Seino, Takashi, Matsushita, Misako, Nishizawa, Toshihiro, Masaoka, Tatsuhiro, Kanai, Takanori
Formato: Artigo
Idioma:Inglês
Publicado em: SAGE Publications 2015
Assuntos:
Original Articles
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4924440/
https://ncbi.nlm.nih.gov/pubmed/27403304
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/2050640615618043
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados